Early COVID-19 XBB.1.5 Vaccine Effectiveness Against Hospitalisation Among Adults Targeted for Vaccination, VEBIS Hospital Network, Europe, October 2023-January 2024
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F65269705%3A_____%2F24%3A00080325" target="_blank" >RIV/65269705:_____/24:00080325 - isvavai.cz</a>
Alternative codes found
RIV/00216224:14110/24:00136914
Result on the web
<a href="https://onlinelibrary.wiley.com/doi/10.1111/irv.13360" target="_blank" >https://onlinelibrary.wiley.com/doi/10.1111/irv.13360</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1111/irv.13360" target="_blank" >10.1111/irv.13360</a>
Alternative languages
Result language
angličtina
Original language name
Early COVID-19 XBB.1.5 Vaccine Effectiveness Against Hospitalisation Among Adults Targeted for Vaccination, VEBIS Hospital Network, Europe, October 2023-January 2024
Original language description
We conducted a multicentre test-negative case-control study covering the period from October 2023 to January 2024 among adult patients aged >= 18 years hospitalised with severe acute respiratory infection in Europe. We provide early estimates of the effectiveness of the newly adapted XBB.1.5 COVID-19 vaccines against PCR-confirmed SARS-CoV-2 hospitalisation. Vaccine effectiveness was 49% overall, ranging between 69% at 14-29 days and 40% at 60-105 days post vaccination. The adapted XBB.1.5 COVID-19 vaccines conferred protection against COVID-19 hospitalisation in the first 3.5 months post vaccination, with VE > 70% in older adults (>= 65 years) up to 1 month post vaccination.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30303 - Infectious Diseases
Result continuities
Project
<a href="/en/project/LM2023049" target="_blank" >LM2023049: Czech National Node of the European Clinical Research Infrastructures Network</a><br>
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2024
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Influenza and Other Respiratory Viruses
ISSN
1750-2640
e-ISSN
1750-2659
Volume of the periodical
18
Issue of the periodical within the volume
8
Country of publishing house
US - UNITED STATES
Number of pages
7
Pages from-to
"e13360"
UT code for WoS article
001291854700001
EID of the result in the Scopus database
2-s2.0-85201271639